Humoral and cell-mediated immunity following vaccination with synthetic Candida cell wall mannan derived heptamannoside-protein conjugate: immunomodulatory properties of heptamannoside-BSA conjugate.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Immunopharmacology

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.intimp.2012.07.004PMID 22835427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carbohydrates and Immunology: Synthetic Oligosaccharide Antigens for Vaccine Formulation

  2011cited by this paper
• Synthesis and bioimmunological efficiency of poly(2-oxazolines) containing a free amino group

  2010cited by this paper
• Model alpha-mannoside conjugates: immunogenicity and induction of candidacidal activity.

  2010influential reference
• Synthesis of a heptasaccharide fragment of the mannan from Candida guilliermondii cell wall and its conjugate with BSA.

  2009influential reference
• A Glycoconjugate Antigen Based on the Recognition Motif of a Broadly Neutralizing Human Immunodeficiency Virus Antibody, 2G12, Is Immunogenic but Elicits Antibodies Unable To Bind to the Self Glycans of gp120

  2008cited by this paper
• Synthetic glycopeptide vaccines combining β-mannan and peptide epitopes induce protection against candidiasis

  2008cited by this paper
• Site-directed conjugation of "clicked" glycopolymers to form glycoprotein mimics: binding to mammalian lectin and induction of immunological function.

  2007cited by this paper
• Evaluation of different mannan polysaccharide usage in enzyme-linked immunosorbent assay for specific antibodies determination.

  2007cited by this paper
• Identification of pH-regulated antigen 1 released from Candida albicans as the major ligand for leukocyte integrin alphaMbeta2.

  2007cited by this paper
• Advances in combating fungal diseases: vaccines on the threshold

  2007influential reference
• Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms.

  2007influential reference
• Identification of pH-Regulated Antigen 1 Released from Candida albicans as the Major Ligand for Leukocyte Integrin αMβ21

  2007cited by this paper
• Immune response to Saccharomyces cerevisiae mannan conjugate in mice.

  2005cited by this paper
• Biological Activities of Naturally Occurring Antibodies Reactive with Candida albicans Mannan

  2004cited by this paper
• Surface Glycans of Candida albicans and Other Pathogenic Fungi: Physiological Roles, Clinical Uses, and Experimental Challenges

  2004cited by this paper
• Candida albicans cell wall glycans, host receptors and responses: elements for a decisive crosstalk.

  2004cited by this paper
• Existence of novel beta-1,2 linkage-containing side chain in the mannan of Candida lusitaniae, antigenically related to Candida albicans serotype A.

  2003cited by this paper
• The pathophysiology and treatment of Candida sepsis

  2002cited by this paper
• Dendritic cells: immune regulators in health and disease.

  2002cited by this paper
• Conjugating oligosaccharides to proteins by squaric acid diester chemistry: rapid monitoring of the progress of conjugation, and recovery of the unused ligand.

  2001cited by this paper
• Complement Is Essential for Protection by an IgM and an IgG3 Monoclonal Antibody Against Experimental, Hematogenously Disseminated Candidiasis1

  2001cited by this paper
• Local Anticandidal Immune Responses in a Rat Model of Vaginal Infection by and Protection against Candida albicans

  2000cited by this paper
• Minimum Chemical Requirements for Adhesin Activity of the Acid-Stable Part of Candida albicans Cell Wall Phosphomannoprotein Complex

  1998cited by this paper
• Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist.

  1998cited by this paper
• A Vaccine and Monoclonal Antibodies That Enhance Mouse Resistance to Candida albicans Vaginal Infection

  1998cited by this paper
• Cell Wall and Secreted Proteins ofCandida albicans: Identification, Function, and Expression

  1998cited by this paper
• Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist.

  1997cited by this paper
• Mannose receptor mediated antigen uptake and presentation in human dendritic cells.

  1997cited by this paper
• Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats

  1997cited by this paper
• Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies

  1997cited by this paper
• Mannose receptor‐mediated uptake of antigens strongly enhances HLA class II‐restricted antigen presentation by cultured dendritic cells

  1997cited by this paper
• CD4+ T-helper-cell responses in mice with low-level Candida albicans infection

  1996cited by this paper
• Antibody response that protects against disseminated candidiasis

  1995influential reference
• Evidence for oligomannosyl residues containing both beta-1,2 and alpha-1,2 linkages as a serotype A-specific epitope(s) in mannans of Candida albicans

  1992cited by this paper
• Sequential nuclear magnetic resonance assignment of beta-1,2-linked mannooligosaccharides isolated from the phosphomannan of the pathogenic yeast Candida albicans NIH B-792 strain.

  1992cited by this paper
• Anticancer Agents, 15. Squaric Acid Diethyl Ester: A New Coupling Reagent for the Formation of Drug Biopolymer Conjugates. Synthesis of Squaric Acid Ester Amides and Diamides

  1991cited by this paper
• Increased immunogenicity of a non-amphipathic protein (BSA) after inclusion into iscoms.

  1990cited by this paper
• Production and characterisation of a monoclonal antibody to a cell-surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species.

  1988cited by this paper
• Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes.

  1985cited by this paper
• 6. Polysaccharides of baker's yeast. Part IV. Mannan

  1961cited by this paper

• Fungal vaccines and adjuvants: a tool to reveal the interaction between host and fungi

  2024cites this paper
• Amphoteric Mannan as an Immune Response Modifier. New Model Immunobiologically Active Candida albicans Mannan-Based Formula

  2023cites this paper
• Role of Protein Glycosylation in Interactions of Medically Relevant Fungi with the Host

  2021cites this paper
• The Role of B-Cells and Antibodies against Candida Vaccine Antigens in Invasive Candidiasis

  2021cites this paper
• Importance of Candida Antigenic Factors: Structure-Driven Immunomodulation Properties of Synthetically Prepared Mannooligosaccharides in RAW264.7 Macrophages

  2019cites this paper
• Immunogenicity of a Glycoconjugate from Hydrazine‐Detoxified Lipopolysaccharide of Vibrio cholerae O139

  2017cites this paper
• Estimation of the degree of conjugation of oligosaccharide haptens to bovine serum albumin in the course of the squarate procedure using gel permeation HPLC

  2016cites this paper
• SUGAR-PROTEIN HYBRIDS FOR BIOMEDICAL APPLICATIONS

  2016cites this paper
• Recent advances in the synthesis of fungal antigenic oligosaccharides

  2016cites this paper
• Glycomaterials for probing host–pathogen interactions and the immune response

  2016cites this paper
• A Blockwise Approach to the Synthesis of (1→2)‐Linked Oligosac­char­ides Corresponding to Fragments of the Acid‐Stable β‐Mannan from the Candida albicans Cell Wall

  2016cites this paper
• DODAB:monoolein liposomes containing Candida albicans cell wall surface proteins: a novel adjuvant and delivery system.

  2015cites this paper
• Humoral immune responses to Candida albicans complement receptor 3-related protein in the atopic subjects with vulvovaginal candidiasis. Novel sensitive marker for Candida infection.

  2015cites this paper
• Immune cell response to Candida cell wall mannan derived branched α-oligomannoside conjugates in mice.

  2015cites this paper
• Blockwise synthesis of a pentasaccharide structurally related to the mannan fragment from the Candida albicans cell wall corresponding to the antigenic factor 6

  2015cites this paper
• Immunological basis of anti‐Candida vaccines focused on synthetically prepared cell wall mannan‐derived manno‐oligomers

  2014cites this paper
• Harnessing What Lies Within: Programming Immunity With Biocompatible Devices to Treat Human Disease

  2013cites this paper
• Effect of Branched α‐Oligomannoside Structures on Induction of Anti‐Candida Humoral Immune Response

  2013cites this paper
• [Eosinophilia in peripheral blood of women with recurrent vaginal candidiasis].

  2013cites this paper
• Synthetically prepared glycooligosaccharides mimicking Candida albicans cell wall glycan antigens--novel tools to study host-pathogen interactions.

  2013cites this paper
• The roles of phosphatidylserine and phosphatidylethanolamine in Candida albicans cell wall maintenance and mitochondrial function

  2012cites this paper